myLaminin Perspectives

Rising clinical trial costs are driven by growing protocol complexity, recruitment challenges, site capacity limits, regulatory burdens, and expanding data demands. These inefficiencies strain sponsors and delay outcomes. By adopting quality-by-design, optimizing protocols, improving patient engagement, and leveraging integrated CTMS and RDM platforms, organizations can reduce costs, enhance compliance, and accelerate clinical research while maintaining data integrity.

Research Data Management is often treated as overhead but the real cost shows up in lost researcher time, duplicated tools, compliance risk, and missed funding opportunities. This article breaks down the hidden financial impact of poor RDM and explains how universities can calculate real ROI. If budgets are tight and accountability is rising, RDM can no longer be an afterthought, it’s a strategic investment.